The central government has amended the Drug Regulations of 1945 as part of a large-scale campaign to combat regulatory fraud in the pharmaceutical sector.
These changes grant regulatory bodies the right to temporarily suspend companies that provide false or fabricated data when attempting to obtain approvals for medicines and related licenses.